tired/exhaustion/severe fatigue; achy/body pain; large round rash on left arm; severe migraine; loss of vision (left eye); Walking difficulty/difficulty walking; headaches; concentration and brain fog; concentration and brain fog; IBS; Chills; Sweats; intermittent sore throat; intermittent temperature; postural orthostatic tachycardia; dizzy light-headed; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 61 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Feb2021 (Lot number: EL9262) at the age of 61 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Fibromyalgia" (unspecified if ongoing); "known allergies Sulfa" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (dose 1, Lot number: EL1284, in left arm), administration date: 15Jan2021, when the patient was 61 years old, for COVID-19 immunization. The following information was reported: DIZZINESS (disability) with onset 05Feb2021, outcome "not recovered", described as "dizzy light-headed"; FATIGUE (disability) with onset 06Feb2021, outcome "not recovered", described as "tired/exhaustion/severe fatigue"; PAIN (disability) with onset 06Feb2021, outcome "not recovered", described as "achy/body pain"; RASH (disability) with onset 05Feb2021, outcome "not recovered", described as "large round rash on left arm"; MIGRAINE (disability) with onset 05Feb2021, outcome "not recovered", described as "severe migraine"; BLINDNESS UNILATERAL (disability) with onset 05Feb2021, outcome "not recovered", described as "loss of vision (left eye)"; GAIT DISTURBANCE (disability) with onset 05Feb2021, outcome "not recovered", described as "Walking difficulty/difficulty walking"; HEADACHE (disability) with onset 05Feb2021, outcome "not recovered", described as "headaches"; DISTURBANCE IN ATTENTION (disability), FEELING ABNORMAL (disability) all with onset 05Feb2021, outcome "not recovered" and all described as "concentration and brain fog"; IRRITABLE BOWEL SYNDROME (disability) with onset 05Feb2021, outcome "not recovered", described as "IBS"; CHILLS (disability) with onset 05Feb2021, outcome "not recovered", described as "Chills"; HYPERHIDROSIS (disability) with onset 05Feb2021, outcome "not recovered", described as "Sweats"; OROPHARYNGEAL PAIN (disability) with onset 05Feb2021, outcome "not recovered", described as "intermittent sore throat"; BODY TEMPERATURE ABNORMAL (disability) with onset 05Feb2021, outcome "not recovered", described as "intermittent temperature"; TACHYCARDIA (disability) with onset 05Feb2021, outcome "not recovered", described as "postural orthostatic tachycardia". The events "dizzy light-headed", "tired/exhaustion/severe fatigue", "achy/body pain", "large round rash on left arm", "severe migraine", "loss of vision (left eye)", "walking difficulty/difficulty walking", "headaches", "concentration and brain fog", "concentration and brain fog", "ibs", "chills", "sweats", "intermittent sore throat", "intermittent temperature" and "postural orthostatic tachycardia" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (2021) negative. Therapeutic measures were taken as a result of dizziness, fatigue, pain, rash, migraine, blindness unilateral, gait disturbance, headache, disturbance in attention, feeling abnormal, irritable bowel syndrome, chills, hyperhidrosis, oropharyngeal pain, body temperature abnormal, tachycardia. Clinical course: Soon after injection, the patient felt dizzy light-headed. Following day, the patient was just tired achy was starting to feel a little better about a week later. The patient developed a large round rash on left arm and increasing severely tired which led to extreme exhaustion, severe migraine, loss of vision (left eye), difficulty walking. When home from work, patient was not able to return since. The patient also developed severe fatigue, headaches, concentration and brain fog, IBS, chills, sweats, body pain, intermittent sore throat, intermittent temperature, and develop postural orthostatic tachycardia. Started on low dose now truck zone and numerous antihistamines as well as numerous other nutrients only minor improvement since the week after vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination.